Bg pattern

ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet

Ultra-Levura 250 mg powder for oral suspension

Saccharomyces boulardiiCNCM I-745

Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.
  • You should consult a doctor if your condition worsens or does not improve after 2 days.

Contents of the leaflet:

  1. What Ultra-Levura is and what it is used for.
  2. What you need to know before taking Ultra-Levura
  3. How to take Ultra-Levura
  4. Possible side effects
  5. Storage of Ultra-Levura
  6. Package contents and additional information

1. What Ultra-Levura is and what it is used for

Ultra-Levura is a medication that contains the probiotic yeast Saccharomyces boulardiias its active ingredient.

It is indicated for the symptomatic treatment of non-specific origin diarrhea and prevention of diarrhea processes produced by antibiotic administration in adults and children.

You should consult a doctor if your condition worsens or does not improve after 2 days of treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Ultra-Levura

Do not take Ultra-Levura:

  • If you are allergic (hypersensitive) to the active ingredient or any of the other components of Ultra-Levura (listed in section 6)
  • If you are allergic (hypersensitive) to yeasts.
  • Patient with central venous catheter (see "Warnings and precautions").
  • Immunocompromised or hospitalized patients due to severe illness or immune system alteration/impairment.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Ultra-Levura.

Be particularly careful with Ultra-Levura:

  • If diarrhea is accompanied by fever or vomiting.
  • In case of blood in the stool
  • In case of very intense thirst or dry mouth sensation, as these are symptoms of dehydration.
  • The sachets should not be opened near patients with a central venous catheter to avoid any colonization, especially those transmitted by hands to the catheter.

Children and adolescents

Administration in children under 2 years of age will require medical advice.

Taking Ultra-Levura with other medications

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Ultra-Levura may interact with medications such as antifungal medications (to treat fungi).

Taking Ultra-Levura with food, beverages, and alcohol

During treatment with Ultra-Levura, do not consume hot beverages or foods (above 50°C), cold foods, or those containing alcohol, as Saccharomyces boulardiicontains live cells.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

The benefit-risk ratio should be evaluated before using it in pregnancy and breastfeeding.

No effects on fertility were detected during animal studies. There are no clinical data; the possible risk to humans is unknown.

Driving and using machines

Ultra-Levura has no influence on the ability to drive and use machines.

Ultra-Levura contains lactose, fructose, and sorbitol (E-420)

This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

This medication contains 471.9 mg of fructose in each sachet. If your doctor has told you that you (or your child) have an intolerance to certain sugars or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult with your doctor before taking this medication.

This medication contains 0.1 mg of sorbitol in each sachet.

3. How to take Ultra-Levura

Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

The dose to be used will depend on the evolution of the symptoms and the lowest effective dose should always be used.

The recommended dose is:

Adults and adolescents from 12 years: 1 to 2 sachets (250 mg to 500 mg) per day, divided into two doses (morning and evening).

Use in children

Children from 2 years: 1 sachet (250 mg) per day.

Administration in children under 2 years of age will require medical advice.

How to take:

This medication is taken orally.

The sachets are taken dissolved in a glass of water.

Administer preferably before meals.

Special populations

Patient with central venous catheter, immunocompromised, or critically ill: This medication is contraindicated in these patients (see section 2). Additionally, due to the risk of airborne contamination, the sachets should not be opened in the rooms of these patients; special precautions should be taken when opening them near the patients, and hands should be washed well after handling the medication.

If you take more Ultra-Levura than you should

If you have taken more Ultra-Levura than you should, consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, go immediately to your doctor or call the Toxicology Information Service (telephone: 91.5620420), indicating the medication and the amount ingested.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, Ultra-Levura can cause side effects, although not everyone will experience them.

The most common side effect, although rare, is flatulence.

The side effects that can occur are:

Infections and infestations

  • Very rare (<1/10,000): yeast penetration into the blood (fungemia).
  • Frequency not known: severe hematological infection (sepsis)

Gastrointestinal disorders

  • Rare (>1/10,000 to <1/1,000): flatulence.
  • Frequency not known (cannot be estimated from available data): constipation.

Immune system disorders

  • Very rare (<1/10,000): anaphylactic reaction with itching, urticaria, skin rash, skin redness, and local or general swelling.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es.

By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Ultra-Levura

Keep this medication out of sight and reach of children.

Store in the original package to protect it from moisture.

Do not use this medication after the expiration date shown on the package after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE collection point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packages and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Ultra-Levura

The active ingredient is Saccharomyces boulardii.

The other components (excipients) are: fructose, lactose, anhydrous colloidal silica, tuttifrutti flavor (contains sorbitol).

Appearance of the product and package contents

Ultra-Levura is presented in sachets with powder for oral suspension.

Each package contains 10 or 20 sachets of powder.

Marketing authorization holder:

BIOCODEX

22 rue des Aqueducs

94250 Gentilly (France)

Manufacturer:

BIOCODEX

1 Avenue Blaise Pascal

60000 Beauvais (France)

Local representative:

Zambon S.A.U.

Maresme 5, Pol. Can Bernades-Subirà

08130 Sta. Perpètua de Mogoda – Barcelona (Spain)

Date of the last revision of this leaflet:July 2021

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION

Discuss questions about ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (1055)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
5.0 (183)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50

Frequently Asked Questions

Is a prescription required for ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION?
ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION?
The active ingredient in ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION is saccharomyces boulardii. This information helps identify medicines with the same composition but different brand names.
Who manufactures ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION?
ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION is manufactured by Biocodex. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ULTRA-LEVURA 250 mg POWDER FOR ORAL SUSPENSION?
Other medicines with the same active substance (saccharomyces boulardii) include ULTRA-LEVURA 250 mg HARD CAPSULES, ULTRA-LEVURA 250 mg POWDER AND SOLVENT FOR ORAL SUSPENSION, ULTRA-LEVURA 50 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media